Literature DB >> 10227390

Evidence for ligand-independent homo-oligomerization of leptin receptor (OB-R) isoforms: a proposed mechanism permitting productive long-form signaling in the presence of excess short-form expression.

D W White1, L A Tartaglia.   

Abstract

The adipocyte secreted hormone leptin (OB) and its receptor (OB-R) are key regulators of mammalian body weight homeostasis. Two predominant isoforms of OB-R have been described: long form (OB-R(L)) characterized as a signal transducing receptor that is highly expressed in specific nuclei of the hypothalamus; and a short, signaling-defective form (OB-R(S)) of indeterminate function that is ubiquitously expressed throughout the body. Receptor chimera studies indicate that OB-R(L) signals via homo-oligomers. However, co-expression experiments have demonstrated that signaling by OB-R(L) is only marginally susceptible to dominant negative suppression by OB-R(S). In the present study we have used receptor epitope tagging to analyze the ligand-independent and -dependent association properties of OB-R(S) and OB-R(L). We present evidence for ligand-independent homo-oligomerization by both receptor isoforms. Ligand treatment of these complexes does not dramatically augment homo-oligomerization. In contrast, hetero-oligomerization between long and short OB-R cannot be detected in the absence of ligand but can be resolved in the presence of ligand. Deletion and substitution mutagenesis of the OB-R(L) intracellular domain indicates that ligand-independent homo-oligomerization by OB-R(L) is sensitive to reduction in JAK kinase recruitment capability, suggesting that JAK interaction and signaling competency may provide means for isoform specific OB-R sorting. These results are discussed with regard to possible mechanisms permitting efficient leptin-induced signaling by OB-R(L) in tissues that co-express OB-R(S).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227390

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Hunting for the functions of short leptin receptor isoforms.

Authors:  Julie Dam; Ralf Jockers
Journal:  Mol Metab       Date:  2013-09-13       Impact factor: 7.422

2.  Uterine artery leptin receptors during the ovarian cycle and pregnancy regulate angiogenesis in ovine uterine artery endothelial cells†.

Authors:  Vladimir E Vargas; Rosalina Villalon Landeros; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

Review 3.  Leptin and breast cancer: an overview.

Authors:  Mehmet Artac; Kadri Altundag
Journal:  Med Oncol       Date:  2011-08-30       Impact factor: 3.064

4.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

5.  The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Authors:  E Ferretti; C Tripodo; G Pagnan; C Guarnotta; D Marimpietri; M V Corrias; D Ribatti; S Zupo; G Fraternali-Orcioni; J L Ravetti; V Pistoia; A Corcione
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

Review 6.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 7.  The Leptin Receptor Complex: Heavier Than Expected?

Authors:  Joris Wauman; Lennart Zabeau; Jan Tavernier
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-21       Impact factor: 5.555

8.  Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents.

Authors:  Yassine Sakar; Corinne Nazaret; Philippe Lettéron; Amal Ait Omar; Mathilde Avenati; Benoît Viollet; Robert Ducroc; André Bado
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

9.  Regulation of intestinal SGLT1 by catestatin in hyperleptinemic type 2 diabetic mice.

Authors:  Jessica A Dominguez Rieg; Venkat R Chirasani; Hermann Koepsell; Sanjib Senapati; Sushil K Mahata; Timo Rieg
Journal:  Lab Invest       Date:  2015-11-09       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.